Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dialysis01:15

Dialysis

575
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
575
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

60
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

181
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
181
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

3.1K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.1K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evidence-Based Recommendations for the Use of Machine Perfusion in Kidney Transplantation.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Reconsidering Urate-Lowering Therapy in Chronic Kidney Disease- Guideline Driven Perspectives on the Management of Asymptomatic Hyperuricaemia.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

The CKD-OSTEO Score: A Chronic Kidney Disease-specific Tool for Osteoporosis Risk Stratification.

TouchREVIEWS in endocrinology·2026
Same author

Social Prescription.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Barofeedback.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Evidence-Based Recommendations for the Use of Desidustat in Chronic Kidney Disease.

JPMA. The Journal of the Pakistan Medical Association·2026
Same journal

Predictors of Altmetric Score in Top-Cited Orthopaedic Articles: A Bibliometric Analysis.

JPMA. The Journal of the Pakistan Medical Association·2026
Same journal

Carbon footprint of waste generated in orthopaedic cases in Pakistan: a pilot descriptive study.

JPMA. The Journal of the Pakistan Medical Association·2026
Same journal

Enhancing quotation accuracy assessment with Chatpdf - a game-changer for a century-old conundrum.

JPMA. The Journal of the Pakistan Medical Association·2026
Same journal

Barriers to implementing simulation-based surgical training for improving quality and safety in developing countries: A short communication.

JPMA. The Journal of the Pakistan Medical Association·2026
Same journal

Intraoperative Adverse Event Reporting in Gastrointestinal Cancer Surgery: A Narrative Review on the Application of ClassIntra.

JPMA. The Journal of the Pakistan Medical Association·2026
Same journal

The Impact of Mortality and Morbidity Meetings on Quality Improvement and Patient Safety.

JPMA. The Journal of the Pakistan Medical Association·2026
查看所有相关文章

相关实验视频

Updated: May 28, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.5K

抑郁症可以透析吗?

Sourabh Sharma1, Sanjay Sanjay2

  • 1Department of Nephrology, VMMC & Safdarjung Hospital, New Delhi, India.

JPMA. The Journal of the Pakistan Medical Association
|February 14, 2025
PubMed
概括
此摘要是机器生成的。

抑郁症在慢性病 (CKD) 中很常见. 透析可以通过消除毒素,改善健康和减少压力来缓解抑郁症状,这表明抑郁症可能是"可透析的".

关键词:
慢性病,抑郁症,透析,中间分子,尿素毒素,焦虑症,ESRD,心理健康

更多相关视频

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.1K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.2K

相关实验视频

Last Updated: May 28, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.5K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.1K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.2K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 精神病学是一个精神病学.
  • 内部医学 内部医学

背景情况:

  • 抑郁症经常与慢性病 (CKD),特别是末期病 (ESKD) 一起发生.
  • 这种并发症源于生物因素,如尿素毒素和炎症,以及心理社会压力因素.
  • 渐进性病的心理负担显著影响患者的幸福感.

研究的目的:

  • 审查慢性病患者抑郁症的病理生理学.
  • 探索启动透析对抑郁症状的影响.
  • 评估抑郁症是否可以被归类为"可透析"的疾病.

主要方法:

  • 关于链接CKD和抑郁症的病理生理机制的文献综述.
  • 对检查透析启动对情绪障碍影响的研究进行分析.
  • 对现有证据的评估,以确定ESKD中抑郁症的透析性质.

主要成果:

  • 尿素毒素 (中间分子) 的积累和慢性炎症有助于CKD的抑郁.
  • 透析可以通过毒素清除,改善身体健康和减轻压力来改善抑郁症状.
  • 有证据表明,透析治疗可能会影响抑郁症.

结论:

  • 在晚期CKD和ESKD中,抑郁症是显著的并发症.
  • 透析为这些患者管理抑郁症提供了潜在的治疗途径.
  • 进一步的研究是有必要的,以充分理解和确认抑郁症作为一个"可透析"实体.